TrialInvestigational new drugs2011
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium.
Srikala S Sridhar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it